Found 5 matching trials
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT) PHASE3 The purpose of this research is to determine if an investigational new drug...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Magnesium Balance of Citrate-based Continuous Venovenous Hemofiltration, Effect of Citrate Dose. NA Rationale:
A higher citrate dose during continuous venovenous hemofiltrati...
Show More Location
Ziekenhuis Oost Limburg
Learn More & Join Trial
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT PHASE3 Prismocitrate 18 is a continuous renal replacement therapy (CRRT) solution ...
Show More Location
University of Alabama at Birmingham/UAB
Learn More & Join Trial
Citrate-based Regional Anticoagulation Versus Heparin for Continuous Renal Replacement Therapy PHASE4 Critically ill patients with acute kidney injury (AKI) are at high risk of ...
Show More Location
University Hospitals of Geneva
Learn More & Join Trial
A Study on the Efficacy and Safety of Continuous Renal Replacement Therapy (CVVHDF) Using a Commercial Citrate-containing Replacement Fluid (Prismocitrate 18/0) NA The investigators aim to examine the efficacy and safety of using a new cit...
Show More Location
Adult Intensive Care unit, Queen Mary Hospital
Learn More & Join Trial